Benjamin Ole Wolthers

Author

Also Known As

B O Wolthers, B. O. Wolthers, BENJAMIN OLE WOLTHERS, Benjamin O Wolthers, Benjamin O. Wolthers, Benjamin Ole Wolthers, Benjamin Wolthers, Pratley R.E, Shaman A.M, Wolthers, Benjamin O.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet University of Copenhagen Aarhus University Hospital Vilnius University National University Hospital of Iceland

About

Benjamin Ole Wolthers is an author at Rigshospitalet specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	344
2	Health Sciences	2	2	40
3	Gastroenterology	2	2	189
4	Diabetes	1	1	21
5	Health Policy	1	1	21

Benjamin Ole Wolthers

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER Ahmed M. Shaman, Stephen C. Bain, George L. Bakris, Circulation	2021	225
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study Benjamin Ole Wolthers, Thomas Leth Frandsen, André Baruchel, The Lancet Oncology Pediatric HematologyAsparaginase-associated PancreatitisGastroenterologyPathologyObservational Ponte	2017	125
International consensus definitions of clinical trial outcomes for kidney failure: 2020 Adeera Levin, Rajiv Agarwal, William G. Herrington, Kidney International	2020	112
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis Johannes F.E. Mann, John B. Buse, Thomas Idorn, Diabetes Obesity and Metabolism	2021	99
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy Kjeld Schmiegelow, Klaus Müller, Signe Sloth Mogensen, F1000Research Hematological MalignancyCapture StrategiesMedicinePediatric HematologyMixed-phenotype Acute Leukemia	2017	93
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study Birgitte Klug Albertsen, Kathrine Grell, Jonas Abrahamsson, Journal of Clinical Oncology	2019	92
Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the <scp>DEVOTE</scp> , <scp>LEADER</scp> and <scp>SUSTAIN</scp> ‐6 cardiovascular outcomes trials Anna R. Kahkoska, Milan S. Geybels, Klara R. Klein, Diabetes Obesity and Metabolism	2020	73
Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age Cecilie Utke Rank, Benjamin Ole Wolthers, Kathrine Grell, Journal of Clinical Oncology	2019	72
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia Sofie Gottschalk Højfeldt, Kathrine Grell, Jonas Abrahamsson, Blood	2020	66
Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol Benjamin Ole Wolthers, Thomas Leth Frandsen, Jonas Abrahamsson, Leukemia UrologyAsparaginase-associated PancreatitisGastroenterologyPathologyMedicine	2016	64

Page 1